Pain is both a symptom and a disease. It manifests in multiple forms and its treatment is complex. Physical, social, economic, and emotional consequences of pain can impair an individual’s overall health, well-being, productivity, and relationships in myriad ways. The impact of pain at a population level is vast and, while estimates differ, the Centers for Disease Control and Prevention reported that 50 million U.S. adults are living in pain. In terms of pain’s global impact, estimates suggest the problem affects approximately 1 in 5 adults across the world, with nearly 1 in 10 adults newly diagnosed with chronic pain each year.
In recent years, the issues surrounding the complexity of pain management have contributed to increased demand for alternative strategies for treating pain. One such strategy is to expand use of topical pain medications—medications applied to intact skin. This nonoral route of administration for pain medication has the potential benefit, in theory, of local activity and fewer systemic side effects. Compounding is an age-old pharmaceutical practice of combining, mixing, or adjusting ingredients to create a tailored medication to meet the needs of a patient. The aim of compounding, historically, has been to provide patients with access to therapeutic alternatives that are safe and effective, especially for people with clinical needs that cannot otherwise be met by commercially available FDA-approved drugs.
Compounded Topical Pain Creams explores issues regarding the safety and effectiveness of the ingredients in these pain creams. This report analyzes the available scientific data relating to the ingredients used in compounded topical pain creams and offers recommendations regarding the treatment of patients.
Table of Contents
|2 Role of Topical Pain Creams in Pain Management||31-44|
|3 Fundamentals, Use, and Common Ingredients in Compounded Topical Pain Creams||45-62|
|4 Gaps in Regulation, Oversight, and Surveillance||63-86|
|5 Science of Compounded Topical Pain Creams||87-120|
|6 A Review of the Safety and Effectiveness of Select Ingredients in Compounded Topical Pain Creams||121-212|
|7 Additional Concerns Related to the Use of Compounded Topical Pain Creams||213-234|
|8 Recommendations Regarding the Treatment of Patients with Compounded Topical Pain Creams||235-240|
|Appendix A: Study Approach||241-246|
|Appendix B: Literature Review||247-256|
|Appendix C: Commissioned Paper: Topical Dosage Form Development and Evaluation||257-278|
|Appendix D: Glossary||279-284|
|Appendix E: 503A and 503B Distribution Supplement||285-286|
|Appendix F: Adverse Events Table||287-304|
|Appendix G: Potential Adverse Effects from Oral Administration of 20 Active Pharmaceutical Ingredients Commonly Used in Compounded Topical Pain Creams||305-312|
|Appendix H: Expanded Discussion on Special Populations to Consider in Pain Management||313-318|
|Appendix I: Biographical Sketches for Committee Members, Fellow, Consultants, and Staff||319-328|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Compounded Topical Pain Creams: Review of Select Ingredients for Safety, Effectiveness, and Use...